General Information


DRAVP ID  DRAVPe02163

Peptide Name   Peptide aldehyde 1

Sequence  ESTLQ

Sequence Length  5

UniProt ID  None  

Taxon ID  None 

Source  Analyses of the SARS-CoV Mpro

Validation   Experimentally Validated



Origin Information


Gene Name/ID  Not Available

GenBank  Not Available

Amino Acid position  Not Available

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Not Available

Chromosomal Position  Not Available



Activity Information


Target Organism  SARS-CoV

Assay  Peptide cleavage assay

Activity 

  • [Ref:21854807]SARS-CoV,IC50=8.27±1.52μM

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity  No cytotoxicity information found in the reference(s) presented

Binding Target  Not Found

Mechanism  tight-binding inhibitors



Structure Information


PDB ID  None

Predicted Structure Download  No predicted structure available

Linear/Cyclic  Linear

N-terminal Modification  Acetylation

C-terminal Modification  Hydogenation

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C23H40N6O11

Absent amino acids  ANDCFPWYVOU

Common amino acids  QELST

Mass  576.6

Pl  4

Basic residues  0

Acidic residues  1

Hydrophobic residues  5

Net charge  -1

Boman Index  1.152

Hydrophobicity  -0.94

Aliphatic Index  78

Half Life 

  •     Mammalian:1 hours
  •     Yeast:30 mins
  •     E.coli:>10 hours

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5



Literature Information


Literature 1

Title   Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease

Pubmed ID   21854807

Reference   Antiviral research, 92(2), 204–212.

Author   Vilas Boas, L. C., de Lima, L. M., Migliolo, L., Mendes, G. D., de Jesus, M. G., Franco, O. L., & Silva, P. A. (2017).

DOI    10.1016/j.antiviral.2011.08.001